Market LIVE
Published markets; coverage varies by country
Product profile · United States

FLUOXETINE HYDROCHLORIDE

 ·  Patent Litigation & Settlement History ↓

IngredientFLUOXETINE HYDROCHLORIDE
Application typeNDA
Application202133
Product001
Dosage formTABLET
RouteORAL
StrengthEQ 60MG BASE
Approval date2011-10-06
Marketing statusDiscontinued
Status event—
ApplicantTWI PHARMS
Product source

Current GenericRadar decision

Year—
SelectionDISCONTINUED
ReviewFINAL
Anchor typeDISCONTINUATION
Anchor date—
Patent anchor—
Exclusivity anchor—
Protection date—
First Final ANDA—
Status event—

Discontinued in the 2026-10-10 product snapshot. The actual discontinuation date is unverified; retain NULL date and year.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
No patent facts are recorded for this product.

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · CURRENT_SNAPSHOT_NO_RECORD · Historical coverage: NOT_COMPLETE

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
209419 / 001FINAL_APPROVAL · FINAL_APPROVED2017-11-16—PH HEALTH LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
209695 / 001FINAL_APPROVAL · FINAL_APPROVED2017-11-20—INVENTIA HEALTHCARE PRIVATE LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211477 / 001FINAL_APPROVAL · FINAL_APPROVED2018-11-21—SOMERSET THERAPEUTICS LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211051 / 001FINAL_APPROVAL · FINAL_APPROVED2018-12-03—TEVA PHARMACEUTICALS USANEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211282 / 001FINAL_APPROVAL · FINAL_APPROVED2019-01-10—SCIEGEN PHARMACEUTICALS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211721 / 001FINAL_APPROVAL · FINAL_APPROVED2019-01-25—DR REDDYS LABORATORIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211632 / 001FINAL_APPROVAL · FINAL_APPROVED2019-02-08—LUPIN LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
212191 / 001FINAL_APPROVAL · FINAL_APPROVED2019-07-05—G AND W LABORATORIES INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
213265 / 001FINAL_APPROVAL · FINAL_APPROVED2020-06-10—AUROBINDO PHARMA LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
212683 / 001FINAL_APPROVAL · FINAL_APPROVED2024-09-13—STRIDES PHARMA GLOBAL PTE LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 10 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
209419 / 001PH HEALTH LTDFINAL_APPROVAL · FINAL_APPROVED2017-11-16 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
209695 / 001INVENTIA HEALTHCARE PRIVATE LTDFINAL_APPROVAL · FINAL_APPROVED2017-11-20 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211477 / 001SOMERSET THERAPEUTICS LLCFINAL_APPROVAL · FINAL_APPROVED2018-11-21 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211051 / 001TEVA PHARMACEUTICALS USAFINAL_APPROVAL · FINAL_APPROVED2018-12-03 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211282 / 001SCIEGEN PHARMACEUTICALS INCFINAL_APPROVAL · FINAL_APPROVED2019-01-10 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211721 / 001DR REDDYS LABORATORIES LTDFINAL_APPROVAL · FINAL_APPROVED2019-01-25 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211632 / 001LUPIN LTDFINAL_APPROVAL · FINAL_APPROVED2019-02-08 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
212191 / 001G AND W LABORATORIES INCFINAL_APPROVAL · FINAL_APPROVED2019-07-05 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
213265 / 001AUROBINDO PHARMA LTDFINAL_APPROVAL · FINAL_APPROVED2020-06-10 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
212683 / 001STRIDES PHARMA GLOBAL PTE LTDFINAL_APPROVAL · FINAL_APPROVED2024-09-13 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.